Filing Details

Accession Number:
0001555280-22-000118
Form Type:
4
Zero Holdings:
No
Publication Time:
2022-03-18 16:38:00
Reporting Period:
2022-03-16
Accepted Time:
2022-03-18 16:38:00
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1555280 Zoetis Inc. ZTS Pharmaceutical Preparations (2834) 460696167
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1640777 Roman Trawicki C/O Zoetis Inc.
10 Sylvan Way
Parsippany NJ 07054
Executive Vice President No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2022-03-16 6,000 $87.51 14,218 No 4 M Direct
Common Stock Disposition 2022-03-16 6,000 $188.15 8,218 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option Disposition 2022-03-16 6,000 $0.00 6,000 $0.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
33,941 No 4 M Direct
Footnotes
  1. The Price reported in Table I, Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $188.10 to $188.21, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  2. Stock options (right to buy Zoetis Inc. common stock) granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan.
  3. 6,000 options granted February 12, 2019 at an exercise price of $87.51 per option.
  4. Each option vests on the third anniversary of the date of grant.
  5. Each option expires on the tenth anniversary of the date of grant.
  6. 7,774 options granted February 12, 2019 at an exercise price of $87.51 per option; 9,581 options granted February 11, 2020 at an exercise price of $144.03 per option; 9,254 options granted February 10, 2021 at an exercise price of $160.62 per option; and 7,332 options granted February 8, 2022 at an exercise price of $201.30 per option.